Medication info

Meticon Tablets (Cimetidine)

Prescription medicationTabletExpired
Ingredient · strength
Cimetidine›200mg / 1 tablet
Manufacturer / importer
Aju Pharmaceutical Co., Ltd.
Appearance
Pale green round film-coated tablet
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Expired

MFDS item code 200300523 · Notified 2003.06.26

This product's status changed to Expired on 2025.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of ulcers and gastroesophageal reflux disease; improvement of gastric mucosal lesions in gastritis; treatment of Zollinger-Ellison syndrome
Who uses it
Adults · Children
Adult dosage
Adults: Administer 400 mg of cimetidine orally twice daily (in the morning and at bedtime), or 800 mg once daily (at bedtime). Alternatively, administer 300 mg orally 4 times daily (after meals and at bedtime). The dose may be increased to 400 mg 4 times daily (after meals and at bedtime) (total 1.6 g). However, to improve gastric mucosal lesions (erosion, bleeding, redness, and edema) associated with the following conditions—acute gastritis and acute exacerbation of chronic gastritis—administer 200 mg twice daily or 400 mg once daily. An antacid may be administered as needed to relieve pain. The dose may be increased in some patients; in such cases, increase the frequency of administration rather than the dose per administration. Do not exceed 2.4 g per day. Patients with renal impairment: Administer 300 mg of this medicine twice daily, every 12 hours. If necessary depending on the patient's symptoms, the frequency may be increased to 3 times daily, every 8 hours, or more often, but use caution. In patients with severe renal impairment, the medicine may accumulate in the body, so reduce the frequency of administration to the minimum necessary according to the patient's response. Hemodialysis lowers the blood cimetidine concentration. After hemodialysis, administer the medicine again according to the schedule. Adjust the dose as appropriate according to age and symptoms.
Children's dosage
Children: Administer 20 〜 40 mg per kg of body weight per day orally in divided doses.

Ingredients

Manufacturer
Aju Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of ulcers and gastroesophageal reflux disease; improvement of gastric mucosal lesions in gastritis; treatment of Zollinger-Ellison syndrome

  • Gastric and duodenal ulcers
  • gastroesophageal reflux disease
  • recurrent ulcers
  • anastomotic ulcers
  • Zollinger-Ellison syndrome
  • gastric mucosal lesions
  • erosion
  • bleeding
  • redness
  • edema
  • acute gastritis
  • and acute exacerbation of chronic gastritis.
View approved original text

This medication is used for various gastrointestinal diseases, including gastric and duodenal ulcers, gastroesophageal reflux disease, recurrent ulcers, surgical anastomosis ulcers, and Zollinger-Ellison syndrome. It is also effective in improving gastric mucosal lesions, such as erosion, bleeding, redness, and edema caused by acute exacerbation of acute gastritis and chronic gastritis. This drug helps protect the gastrointestinal mucosa and relieve symptoms, making it beneficial for intestinal health.

Dosage and Administration

Adult dosage

Adults: Administer 400 mg of cimetidine orally twice daily (in the morning and at bedtime), or 800 mg once daily (at bedtime). Alternatively, administer 300 mg orally 4 times daily (after meals and at bedtime). The dose may be increased to 400 mg 4 times daily (after meals and at bedtime) (total 1.6 g). However, to improve gastric mucosal lesions (erosion, bleeding, redness, and edema) associated with the following conditions—acute gastritis and acute exacerbation of chronic gastritis—administer 200 mg twice daily or 400 mg once daily. An antacid may be administered as needed to relieve pain. The dose may be increased in some patients; in such cases, increase the frequency of administration rather than the dose per administration. Do not exceed 2.4 g per day. Patients with renal impairment: Administer 300 mg of this medicine twice daily, every 12 hours. If necessary depending on the patient's symptoms, the frequency may be increased to 3 times daily, every 8 hours, or more often, but use caution. In patients with severe renal impairment, the medicine may accumulate in the body, so reduce the frequency of administration to the minimum necessary according to the patient's response. Hemodialysis lowers the blood cimetidine concentration. After hemodialysis, administer the medicine again according to the schedule. Adjust the dose as appropriate according to age and symptoms.

Children's dosage

Children: Administer 20 〜 40 mg per kg of body weight per day orally in divided doses.

Precautions

This drug may contain glass fragments when using glass ampoule injections, so extreme caution is required, especially when administering to children or the elderly. Patients with hypersensitivity to any components of this drug or cimetidine, or with a history of such reactions, should not use it. This medication should not be administered to patients taking dofetilide due to the increased risk of cardiac arrhythmias. Patients with impaired renal or hepatic function, a history of drug hypersensitivity, the elderly, children under 19, and patients undergoing hemodialysis should use this medication cautiously, and the dosage may need to be adjusted or the interval prolonged as necessary. This drug can mask symptoms of gastric cancer; therefore, it is important to confirm malignancy before administration. Patients with Helicobacter pylori positive gastric and duodenal ulcers should receive concurrent bacterial eradication treatment. This drug contains specific coloring agents that require caution in patients with allergies to these components. While taking this medication, various side effects, including leukopenia, liver function abnormalities, renal function abnormalities, allergic reactions, gastrointestinal disorders, neurological anomalies, and skin rashes, may occur. If symptoms arise, immediate consultation with medical personnel is required. Elderly patients or those with chronic conditions should be closely monitored for changes in mental state or confusion. This medication may interact with several other drugs, so patients currently taking other medications must inform their healthcare provider, and dosage adjustments may be necessary. Pregnant women or those who may become pregnant should use this medication only when the benefits outweigh the risks, and breastfeeding women should discontinue breastfeeding as it is safer. Safety in children has not been adequately proven; therefore, it should be administered cautiously only when absolutely necessary. Elderly patients often have reduced renal function, which may increase plasma drug concentration, necessitating dosage reduction or increased intervals. Overdose may cause respiratory depression; if symptoms are severe, emergency procedures may include artificial ventilation or gastric lavage. When administered as an injection, a rapid intravenous injection may cause arrhythmias or hypotension, so the infusion should be slow. This drug should be stored out of the reach of children and should not be transferred to other containers. Animal experiments have reported weak anti-androgenic effects and some changes in reproductive organs, but it is known that clinical use has no significant impact on reproductive capacity.

Side effects

  • Leukopenia
  • granulocytopenia
  • agranulocytosis
  • thrombocytopenia
  • pancytopenia
  • aplastic anemia
  • systemic fatigue
  • lethargy
  • subcutaneous hemorrhage
  • mucosal hemorrhage
Show 62 more
  • fever
  • immune hemolytic anemia
  • jaundice
  • hepatitis
  • elevated AST
  • elevated ALT
  • liver dysfunction
  • perivascular liver fibrosis
  • interstitial seizures
  • acute renal failure
  • interstitial nephritis
  • urinary retention
  • elevated BUN
  • elevated serum creatinine
  • shock
  • anaphylactic-like reaction
  • systemic rash
  • dyspnea
  • hypersensitivity vasculitis
  • rash
  • gynecomastia
  • galactorrhea
  • increased vaginal discharge
  • erectile dysfunction
  • abdominal distention
  • constipation
  • diarrhea
  • headache
  • dizziness
  • seizures
  • limb paresthesia
  • rigidity
  • drowsiness
  • hypochondriacal symptoms
  • altered consciousness
  • confusion
  • anxiety
  • psychosis
  • depression
  • agitation
  • hallucinations
  • disorientation
  • bradycardia
  • tachycardia
  • palpitations
  • heart block
  • skin and mucous membrane syndrome
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • Reil syndrome
  • epidermal necrosis
  • erythema multiforme
  • exfoliative dermatitis
  • generalized exfoliative erythema
  • fatigue
  • generalized heat sensation
  • dysuria
  • myalgia
  • arthralgia
  • pancreatitis
  • hair loss
  • polymyositis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container that is air-tight, preferably at a temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the drug's effectiveness for an extended period.

Appearance and packaging

Appearance

Pale green round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.